Meet With...Versant Ventures

Add this event to your calendar:
01/02/2018 11:30 01/02/2018 14:00 America/Los_Angeles Meet With...Versant Ventures Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA JLABS Bay Area false DD/MM/YYYY

Meet With...Versant Ventures

Johnson & Johnson Innovation, JLABS , 329 Oyster Point Blvd , South San Francisco , CA

February 01, 2018 from 11:30 AM to 14:00 PM (PST)

$10 - $35

Committed to transforming the healthcare landscape through innovation, Versant Ventures is eager to help you make an impact in healthcare. Graham Walmsley, MD, Ph.D. and Lev Osherovich, Ph.D. of Versant Ventures will be visiting JLABS @ SSF on February 1, 2018 to provide an overview of Versant's unique investment strategies and meet 1-on-1 with pre-selected companies.

*The one-on-one application process is separate from the event registration process. Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due by January 4th. Apply Here.

Program Overview:
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs who are building the next generation of great healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. With $2.3 billion under management and offices in North America and Europe, Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Since the firm's founding in 1999, nearly 70 Versant companies have achieved successful acquisitions or IPOs.

Graham Walmsley, MD, Ph.D. and Lev Osherovich, Ph.D. will be in attendance to provide an overview presentation of their firm's area of interest. They will be on hand to meet with a handful of applicants 1-on-1 after the presentation. To be considered for a 1-on-1 meeting complete the information required here. Applications due by January 4, 2018.

Graham G. Walmsley | Investment Professional, Versant Ventures read bio»
Lev Osherovich | Director of Innovation Sourcing , Versant Ventures read bio»

10:30AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking Lunch
1:00-5:15 PM | One-on-One Meeting* (30 - minute meetings)

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due January 4, 2018. Apply Here.


$25 | General Public
$35 | Onsite

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Apply to meet one-on-one with Graham Walmsley of Versant Ventures. Your application will be reviewed and you will be notified of acceptance on Wednesday, January 18th, 2018. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Speakers' Biographies:

Graham G. Walmsley | Investment Professional, Versant Ventures

Graham G. Walmsley, M.D., Ph.D. is an Investment Professional at Versant Ventures focused on biotechnology and healthcare investments. Graham joined Versant after completing his training as a Physician Scientist Fellow at Stanford University School of Medicine. At Versant, Graham helped build and launch BlueRock Therapeutics, a regenerative medicine company formed in collaboration with Bayer through one of the largest series A investments ($225M) in biotech history.

Graham received his M.D. and Ph.D. in Stem Cell Biology and Regenerative Medicine from Stanford University and earned his B.A. in Molecular and Cell Biology with summa cum laude honors from the University of California, Berkeley. He conducted his thesis work in the laboratories of Irving Weissman and Michael Longaker with a focus on regenerative medicine, stem cells, and therapeutic approaches to fibrosis. This work was featured in TIME Magazine and resulted in several patents as well as over 60 peer-reviewed publications in journals such as Science and Cell.

Lev Osherovich | Director of Innovation Sourcing, Versant Ventures

Lev Osherovich, Ph.D. is Director of Innovation Sourcing at Versant Ventures, where he focuses on early stage therapeutic investment. Lev trained in Molecular and Cell Biology at UC Berkeley (undergraduate) and in Biochemistry at UCSF, and completed postdoctoral training at University of Kent at Canterbury and UCSF. After leaving academia, he worked as a biotech industry analyst and science journalist at BioCentury and Nature Publishing Group. Since 2014, Lev has worked at Versant and its discovery engine, Inception Sciences, to evaluate academic research with translational potential and to create new portfolio companies.

About the Meet With... Series:

The purpose of the Meet with series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, OrbiMed, Osage University Partners, Spectrum 28, Quark Venture, and AbbVie Ventures.

329 Oyster Point Blvd - 3rd Floor
South San Francisco, California
Map It

JLABS Bay Area

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit or follow @JNJInnovation.

Event contact

Related content